跳至主要内容
临床试验/NCT04071509
NCT04071509已完成不适用

Pilot Study on the Prevention of PNX (Pneumothorax) and Haemorrhagic Complications in Diagnostic Percutaneous Lung Biopsy Procedures Using the MIPP-Kit Device.

BetaGlue Technologies spa6 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年2月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
6
主要终点
Rate of complications associated with percutaneous lung biopsy

研究概览

简要总结

The study will assess the safety and feasibility of a new medical device, MIPP-Kit, for the prevention of complications during diagnostic, CT guided ,percutaneous lung needle biopsy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical indication for diagnostic percutaneous lung biopsy

排除标准

  • Pregnant, or breastfeeding patient (Female)
  • actively participating in other clinical trials in the previous 30 days
  • known allergies to the investigational device components
  • comorbidities that preclude undergoing percutaneous lung biopsy procedure
  • concomitant treatments that preclude undergoing percutaneous lung biopsy procedure

结局指标

主要结局

Rate of complications associated with percutaneous lung biopsy

时间窗: 48 hours after procedure

incidence of clinical complications commonly associated with lung biopsy (pneumothorax and haemorrhage)

次要结局

未报告次要终点

研究者

发起方
BetaGlue Technologies spa
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验